NCT04067115 2025-12-17U01CA236220Sarcoma Alliance for Research through CollaborationPhase 1/2 Completed37 enrolled
NCT03213678 2025-01-27Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Completed18 enrolled 12 charts